281 related articles for article (PubMed ID: 2259403)
1. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage.
Origitano TC; Wascher TM; Reichman OH; Anderson DE
Neurosurgery; 1990 Nov; 27(5):729-39; discussion 739-40. PubMed ID: 2259403
[TBL] [Abstract][Full Text] [Related]
2. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
3. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Mori K; Arai H; Nakajima K; Tajima A; Maeda M
Stroke; 1995 Sep; 26(9):1620-6. PubMed ID: 7660409
[TBL] [Abstract][Full Text] [Related]
4. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
5. Effect of HHH-Therapy on Regional CBF after Severe Subarachnoid Hemorrhage Studied by Bedside Xenon-Enhanced CT.
Engquist H; Rostami E; Ronne-Engström E; Nilsson P; Lewén A; Enblad P
Neurocrit Care; 2018 Apr; 28(2):143-151. PubMed ID: 28983856
[TBL] [Abstract][Full Text] [Related]
6. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage.
Vermeij FH; Hasan D; Bijvoet HW; Avezaat CJ
Stroke; 1998 May; 29(5):924-30. PubMed ID: 9596236
[TBL] [Abstract][Full Text] [Related]
7. [Intensive care using hypervolemic hypertensive hemodilution in the acute period of subarachnoidal hemorrhages in patients with arterial aneurysms].
Kurdiumova NV; Parfenov AL; Fokin MS; Grinenko EA; Eliava ShSh; Kheĭreddin AS; Sazonov IA
Zh Vopr Neirokhir Im N N Burdenko; 2006; (2):48-53. PubMed ID: 16827430
[TBL] [Abstract][Full Text] [Related]
8. Temporal Dynamics of Cerebral Blood Flow During the Acute Course of Severe Subarachnoid Hemorrhage Studied by Bedside Xenon-Enhanced CT.
Engquist H; Rostami E; Enblad P
Neurocrit Care; 2019 Apr; 30(2):280-290. PubMed ID: 30790226
[TBL] [Abstract][Full Text] [Related]
9. Controlled Hypercapnia Enhances Cerebral Blood Flow and Brain Tissue Oxygenation After Aneurysmal Subarachnoid Hemorrhage: Results of a Phase 1 Study.
Westermaier T; Stetter C; Kunze E; Willner N; Holzmeier J; Weiland J; Koehler S; Lotz C; Kilgenstein C; Ernestus RI; Roewer N; Muellenbach RM
Neurocrit Care; 2016 Oct; 25(2):205-14. PubMed ID: 26886010
[TBL] [Abstract][Full Text] [Related]
10. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
Romero Kräuchi O; Verger Bennasar AM
Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
[TBL] [Abstract][Full Text] [Related]
11. Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage. Is it efficacious? Yes.
Ullman JS; Bederson JB
Crit Care Clin; 1996 Jul; 12(3):697-707. PubMed ID: 8839601
[TBL] [Abstract][Full Text] [Related]
12. Hypervolemic hemodilution: a new approach to subarachnoid hemorrhage.
Stewart-Amidei C
Heart Lung; 1989 Nov; 18(6):590-8. PubMed ID: 2684918
[TBL] [Abstract][Full Text] [Related]
13. Changes in Cerebral Perfusion with Induced Hypertension in Aneurysmal Subarachnoid Hemorrhage: A Pilot and Feasibility Study.
Murphy A; de Oliveira Manoel AL; Macdonald RL; Baker A; Lee TY; Marotta T; Montanera W; Aviv R; Bharatha A
Neurocrit Care; 2017 Aug; 27(1):3-10. PubMed ID: 28244000
[TBL] [Abstract][Full Text] [Related]
14. Controlled transient hypercapnia: a novel approach for the treatment of delayed cerebral ischemia after subarachnoid hemorrhage?
Westermaier T; Stetter C; Kunze E; Willner N; Holzmeier J; Kilgenstein C; Lee JY; Ernestus RI; Roewer N; Muellenbach RM
J Neurosurg; 2014 Nov; 121(5):1056-62. PubMed ID: 25148012
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravascular volume expansion on cerebral blood flow in patients with ruptured cerebral aneurysms.
Yamakami I; Isobe K; Yamaura A
Neurosurgery; 1987 Sep; 21(3):303-9. PubMed ID: 3670573
[TBL] [Abstract][Full Text] [Related]
16. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
17. Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage.
Solomon RA; Fink ME; Lennihan L
Neurosurgery; 1988 Dec; 23(6):699-704. PubMed ID: 3216966
[TBL] [Abstract][Full Text] [Related]
18. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH; Lukovits T; Friedman JA
Neurocrit Care; 2006; 4(1):68-76. PubMed ID: 16498198
[TBL] [Abstract][Full Text] [Related]
19. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review.
Dankbaar JW; Slooter AJ; Rinkel GJ; Schaaf IC
Crit Care; 2010; 14(1):R23. PubMed ID: 20175912
[TBL] [Abstract][Full Text] [Related]
20. Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage.
Tagami T; Kuwamoto K; Watanabe A; Unemoto K; Yokobori S; Matsumoto G; Igarashi Y; Yokota H;
Neurocrit Care; 2014 Dec; 21(3):462-9. PubMed ID: 24865266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
